Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.820
-0.030 (-1.62%)
At close: Aug 8, 2025, 4:00 PM
1.850
+0.030 (1.65%)
After-hours: Aug 8, 2025, 4:59 PM EDT

Fortress Biotech Stock Forecast

Stock Price Forecast

The 2 analysts that cover Fortress Biotech stock have a consensus rating of "Strong Buy" and an average price target of $21, which forecasts a 1,053.85% increase in the stock price over the next year. The lowest target is $16 and the highest is $26.

Price Target: $21 (+1,053.85%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$16$21$26$26
Change+779.12%+1053.8%+1328.6%+1328.6%
* Price targets were last updated on Mar 11, 2025.

Analyst Ratings

The average analyst rating for Fortress Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222222
Buy111110
Hold000000
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Roth MKM
Roth MKM
Strong Buy
Reiterates
$15$16
Strong BuyReiterates$15$16+779.12%Mar 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$24$26
Strong BuyMaintains$24$26+1,328.57%Nov 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$24
Strong BuyReiterates$24+1,218.68%Jul 19, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
BuyReiteratesn/an/aJun 20, 2024
Roth MKM
Roth MKM
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+449.45%May 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
87.43M
from 57.68M
Increased by 51.59%
Revenue Next Year
126.54M
from 87.43M
Increased by 44.74%
EPS This Year
-1.43
from -2.69
EPS Next Year
-0.84
from -1.43
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
45.60M68.79M75.74M84.51M57.68M87.43M126.54M202.78M
Revenue Growth
24.49%50.86%10.11%11.58%-31.76%51.59%44.74%60.25%
EPS
-9.69-11.88-15.97-8.47-2.69-1.43-0.84-0.47
EPS Growth
--------
Forward PE
--------
No. Analysts
-----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High108.2M154.1M208.7M
Avg87.4M126.5M202.8M
Low67.0M99.3M194.8M

Revenue Growth

Revenue Growth202520262027
High
87.7%
76.3%
65.0%
Avg
51.6%
44.7%
60.2%
Low
16.1%
13.6%
54.0%

EPS Forecast

EPS202520262027
High-1.26-0.47-0.48
Avg-1.43-0.84-0.47
Low-1.57-1.18-0.45

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.